rs7307229

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002046.7(GAPDH):​c.-156C>G variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0382 in 320,268 control chromosomes in the GnomAD database, including 1,079 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.067 ( 1009 hom., cov: 33)
Exomes 𝑓: 0.012 ( 70 hom. )

Consequence

GAPDH
NM_002046.7 upstream_gene

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.09

Publications

2 publications found
Variant links:
Genes affected
GAPDH (HGNC:4141): (glyceraldehyde-3-phosphate dehydrogenase) This gene encodes a member of the glyceraldehyde-3-phosphate dehydrogenase protein family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. The product of this gene catalyzes an important energy-yielding step in carbohydrate metabolism, the reversible oxidative phosphorylation of glyceraldehyde-3-phosphate in the presence of inorganic phosphate and nicotinamide adenine dinucleotide (NAD). The encoded protein has additionally been identified to have uracil DNA glycosylase activity in the nucleus. Also, this protein contains a peptide that has antimicrobial activity against E. coli, P. aeruginosa, and C. albicans. Studies of a similar protein in mouse have assigned a variety of additional functions including nitrosylation of nuclear proteins, the regulation of mRNA stability, and acting as a transferrin receptor on the cell surface of macrophage. Many pseudogenes similar to this locus are present in the human genome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
GAPDH-DT (HGNC:55492): (GAPDH divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.216 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002046.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAPDH
NM_002046.7
MANE Select
c.-156C>G
upstream_gene
N/ANP_002037.2
GAPDH
NM_001289745.3
c.-248C>G
upstream_gene
N/ANP_001276674.1
GAPDH
NM_001289746.2
c.-396C>G
upstream_gene
N/ANP_001276675.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAPDH
ENST00000229239.10
TSL:1 MANE Select
c.-156C>G
upstream_gene
N/AENSP00000229239.5
GAPDH
ENST00000396861.5
TSL:5
c.-248C>G
upstream_gene
N/AENSP00000380070.1
GAPDH
ENST00000396856.5
TSL:5
c.-408C>G
upstream_gene
N/AENSP00000380065.1

Frequencies

GnomAD3 genomes
AF:
0.0665
AC:
10099
AN:
151936
Hom.:
999
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.219
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0303
Gnomad ASJ
AF:
0.0121
Gnomad EAS
AF:
0.000974
Gnomad SAS
AF:
0.0451
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.00284
Gnomad OTH
AF:
0.0468
GnomAD4 exome
AF:
0.0124
AC:
2085
AN:
168206
Hom.:
70
Cov.:
0
AF XY:
0.0162
AC XY:
1515
AN XY:
93740
show subpopulations
African (AFR)
AF:
0.144
AC:
185
AN:
1284
American (AMR)
AF:
0.0124
AC:
62
AN:
5000
Ashkenazi Jewish (ASJ)
AF:
0.00884
AC:
31
AN:
3506
East Asian (EAS)
AF:
0.000260
AC:
1
AN:
3842
South Asian (SAS)
AF:
0.0400
AC:
1469
AN:
36692
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9220
Middle Eastern (MID)
AF:
0.0247
AC:
15
AN:
608
European-Non Finnish (NFE)
AF:
0.00205
AC:
204
AN:
99596
Other (OTH)
AF:
0.0140
AC:
118
AN:
8458
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
86
172
258
344
430
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0667
AC:
10146
AN:
152062
Hom.:
1009
Cov.:
33
AF XY:
0.0655
AC XY:
4869
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.220
AC:
9120
AN:
41490
American (AMR)
AF:
0.0303
AC:
463
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.0121
AC:
42
AN:
3472
East Asian (EAS)
AF:
0.000976
AC:
5
AN:
5124
South Asian (SAS)
AF:
0.0451
AC:
215
AN:
4772
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.00284
AC:
193
AN:
67990
Other (OTH)
AF:
0.0468
AC:
99
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
395
790
1184
1579
1974
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0514
Hom.:
70
Bravo
AF:
0.0748
Asia WGS
AF:
0.0380
AC:
131
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.36
DANN
Benign
0.69
PhyloP100
-2.1
PromoterAI
0.055
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7307229; hg19: chr12-6643603; API